Relevance of cognitive deterioration in early relapsing-remitting MS: A 3-year follow-up study

Multiple Sclerosis

Volumn 16, Issue 12, 2010, Pages 1474-1482

  Amato, Maria P ^a   Portaccio, Emilio ^a   Goretti, Benedetta ^a   Zipoli, Valentina ^a   Iudice, Alfonso ^a   Pina, Dario Della ^b   Malentacchi, Gianmichele ^c   Sabatini, Simonetta ^d   Annunziata, Pasquale ^e   Falcini, Mario ^f   Mazzoni, Monica ^g   Mortilla, Marzia ^h   Fonda, Claudio ^h   De Stefano, Nicola ^e  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Hospital of Carrara   (Italy)

^c Hospital of Arezzo   (Italy)

^d Hospital of Terni   (Italy)

^e UNIVERSITY OF SIENA   (Italy)

^f Hospital of Prato   (Italy)

^g Hospital of Lucca   (Italy)

^h UNIVERSITY OF FLORENCE   (Italy)

Author keywords

cognitive impairment; longitudinal assessment; magnetic resonance; relapsing remitting multiple sclerosis

Indexed keywords

GADOLINIUM; INTERFERON BETA SERINE;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEPRESSION; DISABILITY; DISEASE COURSE; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MALE; MENTAL DETERIORATION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PSYCHOMETRY; RELAPSE; REMISSION; SCORING SYSTEM;

ADULT; COGNITION; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROPSYCHOLOGICAL TESTS;

EID: 78650160051     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458510380089     Document Type: Article

References (44)

1. Amato MP, Zipoli V. and Portaccio E. Cognitive changes in multiple sclerosis. Expert Rev Neurother 2008 ; 8: 1585-1596.
2. Amato MP, Ponziani G., Siracusa G. and Sorbi S. Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol 2001 ; 58: 1602 1606.
3. Zivadinov R., Sepcic J., Nasuelli D., et al. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2001 ; 70: 773 780.
4. Camp SJ, Stevenson VL, Thompson AJ, et al. A longitudinal study of cognition in primary progressive multiple sclerosis. Brain 2005 ; 128: 2891 2898.
5. Kujala P., Portin R. and Ruutiainen J. The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up. Brain 1997 ; 120:.
6. Jennekens-Schinkel A., Laboyrie PM, Lanser JB and van der Velde EA Cognition in patients with multiple sclerosis after four years. J Neurol Sci 1990 ; 99: 229 247.
7. Mariani C., Farina E., Cappa SF, et al. Neuropsychological assessment in multiple sclerosis: a follow-up study with magnetic resonance imaging. J Neurol 1991 ; 238: 395 400.
8. Hohol MJ, Guttmann CR, Orav J., et al. Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis. Arch Neurol 1997 ; 54: 1018-1025.
9. Filley CM, Heaton RK, Nelson LM, Burks JS and Franklin GM A comparison of dementia in Alzheimer's disease and multiple sclerosis. Arch Neurol 1989 ; 46: 157-161.
10. Rosti E., Hamalainen P., Koivisto K. and Hokkanen L. One-year follow-up study of relapsing remitting MS patients' cognitive performances: Paced Auditory Serial Addition Test's susceptibility to change. J Int Neuropsychol Soc 2007 ; 13: 791-798.
11. Feinstein A., Brown R. and Ron M. Effects of practice of serial tests of attention in healthy subjects. J Clin Exp Neuropsychol 1994 ; 16: 436-447.
12. Feinstein A., Ron M. and Thompson A. A serial study of psychometric and magnetic resonance imaging changes in multiple sclerosis. Brain 1993 ; 116: 569-602.
13. Weinstein A., Schwid SR, Schiffer RB, McDermott MP, Giang DW and Goodman AD Neuropsychologic status in multiple sclerosis after treatment with glatiramer. Arch Neurol 1999 ; 56: 319-324.
14. Fischer JS, Priore RL, Jacobs LD, et al. Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. Ann Neurol 2000 ; 48: 885-892.
15. Poser CM, Paty DW, Scheinberg L., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983 ; 13: 227-231.
16. Kurtzke JF Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983 ; 33: 1444-1452.
17. Rao S. A manual for the Brief Repeatable Battery of Neuropsychological Tests in multiple sclerosis. Milwaukee, WI: Medical College of Wisconsin, 1990.
18. Barbarotto R., Laiacona M., Frosio R., Vecchio M., Farinato A. and Capitani E. A normative study on visual reaction times and two Stroop colour-word tests. Ital J Neurol Sci 1998 ; 19: 161-170.
19. Montgomery SA and Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979 ; 134: 382-389.
20. Krupp LB, LaRocca NG, Muir-Nash J. and Steinberg AD The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989 ; 46: 1121-1123.
21. Smith SM, De Stefano N., Jenkinson M. and Matthews PM Normalized accurate measurement of longitudinal brain change. J Comput Assist Tomogr 2001 ; 25: 466-475.
22. Smith SM, Zhang Y., Jenkinson M., et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002 ; 17: 479-489.
23. Camp SJ, Stevenson VL, Thompson AJ, et al. Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates. Brain 1999 ; 122: 1341-1348.
24. Jacobson NS and Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991 ; 59: 12-19.
25. Martin R., Griffith HR, Sawrie S., Knowlton R. and Faught E. Determining empirically based self-reported cognitive change: development of reliable change indices and standardized regression-based change norms for the multiple abilities self-report questionnaire in an epilepsy sample. Epilepsy Behav 2006 ; 8: 239-245.
26. Amato MP, Portaccio E., Goretti B., et al. The Rao's Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population. Mult Scler 2006 ; 12: 787-793.
27. Achiron A. and Barak Y. Cognitive impairment in probable multiple sclerosis. J Neurol Neurosurg Psychiatry 2003 ; 74: 443-446.
28. Glanz B., Holland C., Gauthier S., et al. Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Mult Scler 2007 ; 13: 1004-1010.
29. Deloire MS, Bonnet MC, Salort E., et al. How to detect cognitive dysfunction at early stages of multiple sclerosis? Mult Scler 2006 ; 12: 445-452.
30. Pliskin NH, Hamer DP, Goldstein DS, et al. Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b. Neurology 1996 ; 47: 1463-1468.
31. Freedman MS, Kappos L., Polman CH, et al. Impact of early interferon beta-1b treatment on disease evolution over five years in patients with a first event suggestive of multiple sclerosis. Mult Scler 2008 ; 14: S295 - S296.
32. Benedict RH, Duquin JA, Jurgensen S., et al. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire. Mult Scler 2008 ; 14: 940-946.
33. Drake A., Weinstock-Guttman B., Morrow S., Hojnacki D., Munschauer F. and Benedict R. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test. Mult Scler, 2010 ; 16 (2). 228-237.
34. Arnett PA, Rao SM, Bernardin L., Grafman J., Yetkin FZ and Lobeck L. Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis. Neurology 1994 ; 44: 420-425.
35. Foong J., Rozewicz L., Quaghebeur G., et al. Executive function in multiple sclerosis. The role of frontal lobe pathology. Brain 1997 ; 120: 15-26.
36. Rao SM, Leo GJ, Haughton VM, St Aubin-Faubert P. and Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 1989 ; 39: 161-166.
37. Swirsky-Sacchetti T., Mitchell DR, Seward J., et al. Neuropsychological and structural brain lesions in multiple sclerosis: a regional analysis. Neurology 1992 ; 42: 1291-1295.
38. Rovaris M., Filippi M., Falautano M., et al. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology 1998 ; 50: 1601-1608. (Pubitemid 28283224)
39. Rovaris M., Comi G. and Filippi M. MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction. J Neurol Sci 2006 ; 245: 111-116.
40. Benedict RH, Bruce JM, Dwyer MG, et al. Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. Arch Neurol 2006 ; 63: 1301-1306.
41. Benedict RH, Zivadinov R., Carone DA, et al. Regional lobar atrophy predicts memory impairment in multiple sclerosis. AJNR Am J Neuroradiol 2005 ; 26: 1824-1831.
42. Amato MP, Bartolozzi ML, Zipoli V., et al. Neocortical volume decrease in relapsing remitting MS patients with mild cognitive impairment. Neurology 2004 ; 63: 89-93
43. Amato MP, Portaccio E., Goretti B., et al. Association of neocortical volume changes with cognitive deterioration in relapsing remitting multiple sclerosis. Arch Neurol 2007 ; 64: 1157-1161.
44. Houtchens MK, Benedict RH, Killiany R., et al. Thalamic atrophy and cognition in multiple sclerosis. Neurology 2007 ; 69: 1213-1223.